Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Smyth

Showing results (201-210 of 294) with videos related to

Pageof 30
Sort By:
British Journal of Cancer|March 1, 1996
Metabolism of the broad-spectrum neuropeptide growth factor antagonist: [D-Arg1, D-Phe5, D-Trp7,9, Leu11]-substance PD A Jones, J Cummings, S P Langdon, et al.
British Journal of Cancer|December 18, 2001
Association of c-Raf expression with survival and its targeting with antisense oligonucleotides in ovarian cancerF McPhillips, P Mullen, B P Monia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1995
Pharmacokinetics, metabolism, tissue and tumour distribution of the neuropeptide growth factor antagonist [Arg6, D-Trp7,9, NmePhe8]- substance P(6-11) in nude mice bearing the H69 small-cell lung cancer xenograftJ Cummings, A J MacLellan, D A Jones, et al.
The Quarterly Journal of Medicine|October 1, 1986
The impact of chemotherapy on small cell carcinoma of the bronchusJ F Smyth, S M Fowlie, A Gregor, et al.
Cancer Chemotherapy and Pharmacology|October 15, 1998
Growth-inhibitory effects of the synthetic retinoid CD437 against ovarian carcinoma models in vitro and in vivoS P Langdon, G J Rabiasz, A A Ritchie, et al.
Lancet (London, England)|May 3, 2003
Stapled versus excision haemorrhoidectomy: long-term follow up of a randomised controlled trialEdward F Smyth, Richard P Baker, Bert J Wilken, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2001
Forearm blood flow and local responses to peptide vasodilators: a novel pharmacodynamic measure in the phase I trial of antagonist G, a neuropeptide growth factor antagonistS Clive, D J Webb, A MacLellan, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Growth inhibition of oestrogen receptor-positive human ovarian carcinoma by anti-oestrogens in vitro and in a xenograft modelS P Langdon, A J Crew, A A Ritchie, et al.
Cancer Treatment Reports|March 1, 1982
Tumor size, response rate, and prognosis in small cell carcinoma of the bronchus treated by combination chemotherapyP G Harper, R L Souhami, S G Spiro, et al.
British Journal of Cancer|May 31, 2001
Adjuvant interferon alpha 2b in high risk melanoma - the Scottish studyD A Cameron, M C Cornbleet, R M Mackie, et al.
Pageof 30

Showing results (201-210 of 294) with videos related to

Sort By:
Pageof 30
British Journal of Cancer|March 1, 1996
Metabolism of the broad-spectrum neuropeptide growth factor antagonist: [D-Arg1, D-Phe5, D-Trp7,9, Leu11]-substance PD A Jones, J Cummings, S P Langdon, et al.
British Journal of Cancer|December 18, 2001
Association of c-Raf expression with survival and its targeting with antisense oligonucleotides in ovarian cancerF McPhillips, P Mullen, B P Monia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1995
Pharmacokinetics, metabolism, tissue and tumour distribution of the neuropeptide growth factor antagonist [Arg6, D-Trp7,9, NmePhe8]- substance P(6-11) in nude mice bearing the H69 small-cell lung cancer xenograftJ Cummings, A J MacLellan, D A Jones, et al.
The Quarterly Journal of Medicine|October 1, 1986
The impact of chemotherapy on small cell carcinoma of the bronchusJ F Smyth, S M Fowlie, A Gregor, et al.
Cancer Chemotherapy and Pharmacology|October 15, 1998
Growth-inhibitory effects of the synthetic retinoid CD437 against ovarian carcinoma models in vitro and in vivoS P Langdon, G J Rabiasz, A A Ritchie, et al.
Lancet (London, England)|May 3, 2003
Stapled versus excision haemorrhoidectomy: long-term follow up of a randomised controlled trialEdward F Smyth, Richard P Baker, Bert J Wilken, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2001
Forearm blood flow and local responses to peptide vasodilators: a novel pharmacodynamic measure in the phase I trial of antagonist G, a neuropeptide growth factor antagonistS Clive, D J Webb, A MacLellan, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Growth inhibition of oestrogen receptor-positive human ovarian carcinoma by anti-oestrogens in vitro and in a xenograft modelS P Langdon, A J Crew, A A Ritchie, et al.
Cancer Treatment Reports|March 1, 1982
Tumor size, response rate, and prognosis in small cell carcinoma of the bronchus treated by combination chemotherapyP G Harper, R L Souhami, S G Spiro, et al.
British Journal of Cancer|May 31, 2001
Adjuvant interferon alpha 2b in high risk melanoma - the Scottish studyD A Cameron, M C Cornbleet, R M Mackie, et al.
Pageof 30